@inproceedings{inproceedings, title  = {{A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: The ETOP and EORTC SPLENDOUR trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2018}},

 month = {{10}},

 author = {{Peters S and Danson SJ and Hasan B and Reinmuth N and Majem M and Tournoy KG and Mark MT and Pless M and Cobo M and Rodriguez-Abreu D and Falchero L et al}},

 doi = {{10.1093/annonc/mdy292.008}},

 volume = {{29}},

 journal = {{Annals of Oncology}},

 pages = {{viii498-viii498}},

 note = {{Accessed on 2024/09/19}}}